From: The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells
Peptides
FEMX
aIC50 (μM)
HT-29
IC50 (μM)
Ratio(IC50)HT-29 cells/FEMX cells
LfcinB
40 ± 7
148 ± 8
3.7
KW5
30 ± 3
55 ± 14
1.8